Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
+4
Published on August 29
The $10 billion private equity takeover and five-way breakup of Walgreens creates unprecedented opportunities for competitors to capture market share in a rapidly changing healthcare landscape.
With a major player restructuring, pharmaceutical distributors and specialised healthcare providers are positioned to benefit from new strategic partnerships and increased demand for their services.
This tactical, event-driven investment approach targets companies that could see immediate benefits from the disruption, making it a timely opportunity for investors seeking to capitalise on industry change.
The $10 billion private equity takeover and breakup of Walgreens represents a major industry catalyst. This restructuring signals a shift towards specialisation as healthcare companies compete with giants like CVS and Amazon. The fragmentation of a major player could unlock significant opportunities for competitors and specialised service providers.
This group focuses on companies positioned to benefit from Walgreens' restructuring. It includes direct competitors, pharmaceutical distributors, and specialised healthcare providers. The move from public to private ownership allows for aggressive long-term restructuring without quarterly earnings pressure, creating a more dynamic competitive landscape.
These stocks were handpicked by professional analysts based on their potential to capitalise on the disruption caused by Walgreens' breakup. Each company is positioned to gain market share, forge new strategic alliances, or benefit from the more competitive environment created by this major industry reorganisation.
Market capitalisation breakdown for a healthcare-focused basket following Walgreens' restructuring theme.
CVS: $105.32B
BTSG: $5.84B
PRGO: $3.02B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
In 12 months it might be worth:
+341.69%
On average, analysts expect assets in this group to grow 341.69% over the next year.
10 of 14 assets in this group are rated Buy by professional analysts.
